270 related articles for article (PubMed ID: 32885274)
1. An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure. Lin S; Shaik N; Chan G; Cortes JE; Ruiz-Garcia A Cancer Chemother Pharmacol; 2020 Oct; 86(4):451-459. PubMed ID: 32885274 [TBL] [Abstract][Full Text] [Related]
2. Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial. Ann Hematol; ; . PubMed ID: 33740113 [TBL] [Abstract][Full Text] [Related]